Literature DB >> 14720502

A blockade in Wnt signaling is activated following the differentiation of F9 teratocarcinoma cells.

Sayumi Shibamoto1, Jane Winer, Mickey Williams, Paul Polakis.   

Abstract

Aberrant activation of the Wnt signaling pathway is a common event in human tumor progression. Wnt signaling has also been implicated in maintaining a variety of adult and embryonic stem cells by imposing a restraint to differentiation. To understand the effect of Wnt signaling on the differentiation of epithelial cells, we used mouse teratocarcinoma F9 cells as a model. The F9 cells can be differentiated into visceral endoderm (VE) resembling absorptive columnar epithelial cells. We performed comparative gene expression analysis on retinoic acid-differentiated and undifferentiated F9 cells and confirmed that markers of VE and intestinal epithelium were induced upon differentiation. The induction of these markers by retinoic acid was reduced in the presence of Wnt, although Wnt alone did not change their expression. This suggests that Wnt signaling inhibited the differentiation of F9 cells by altering gene expression. This inhibition was also reflected in the morphology of the F9 cells as their apical-basal polarity was disrupted by inclusion of Wnt during differentiation. These results support a model in which Wnt modulates the expression of genes required for normal terminal differentiation of the stem cells. However, it follows that progenitor cells must escape from Wnt signaling to attain the differentiated state. Accordingly, we found that differentiated F9 cells no longer responded to Wnt and that a blockade in Wnt signaling occurred upstream of Axin. Consistent with this, Wnt negative regulators, such as Dickkopf-1 and Disabled-2, were induced upon the differentiation of F9 cells. We propose that a similar system to produce Wnt inhibitors regulates homeostasis of certain stem cell compartments in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720502     DOI: 10.1016/j.yexcr.2003.08.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass.

Authors:  Luke H Hoeppner; Frank J Secreto; David F Razidlo; Tiffany J Whitney; Jennifer J Westendorf
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

2.  Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.

Authors:  Tadahiro Nagaoka; Hideaki Karasawa; Thomas Turbyville; Maria-Cristina Rangel; Nadia P Castro; Monica Gonzales; Alyson Baker; Masaharu Seno; Stephen Lockett; Yoshimi E Greer; Jeffrey S Rubin; David S Salomon; Caterina Bianco
Journal:  Cell Signal       Date:  2012-09-27       Impact factor: 4.315

3.  Defining the roles of beta-catenin and plakoglobin in LEF/T-cell factor-dependent transcription using beta-catenin/plakoglobin-null F9 cells.

Authors:  Masayuki Shimizu; Yoshitaka Fukunaga; Junichi Ikenouchi; Akira Nagafuchi
Journal:  Mol Cell Biol       Date:  2007-11-05       Impact factor: 4.272

4.  The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin.

Authors:  Y Jiang; C Prunier; P H Howe
Journal:  Oncogene       Date:  2007-10-08       Impact factor: 9.867

5.  Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation.

Authors:  Luke H Hoeppner; Frank Secreto; Eric D Jensen; Xiaodong Li; Rachel A Kahler; Jennifer J Westendorf
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

Review 6.  Retinoids in Cutaneous Squamous Cell Carcinoma.

Authors:  Helen B Everts; Eleonore-Nausica Akuailou
Journal:  Nutrients       Date:  2021-01-05       Impact factor: 5.717

Review 7.  Role of TCF/LEF Transcription Factors in Bone Development and Osteogenesis.

Authors:  Zhengqiang Li; Zhimin Xu; Congcong Duan; Weiwei Liu; Jingchun Sun; Bing Han
Journal:  Int J Med Sci       Date:  2018-09-07       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.